Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The research, led by Isaac Harris, PhD, at the Wilmot Cancer Institute, reveals that tumors may be addicted to glutathione, opening new possibilities for targeted cancer therapies
It accomplishes this as a component of the enzyme glutathione peroxidase (GPx)
Mtor: a pharmacologic target for autophagy regulation
Often stacked with MOTS-c and SS-31 in longevity protocols as the three key MDPs
Convenient but may be fully destroyed by stomach acidity before reaching systemic circulation
Data availability The datasets generated and/or analyzed during the current study are not publicly available because they contain PII (birthdates) but are available in a de-identified fashion from the corresponding author on reasonable request
US$ 23.53
US$ 27.98
US$ 20.09
US$ 22.22
US$ 23.95
